SCHEMBL631911

SCHEMBL631911

O=C(O)CCCC(=O)O[SiH3]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.58
SLC22A6 Q4U2R8 1/20 0.58
LMNA P02545 4/20 0.50
NFKB1 P19838 2/20 0.48
PMP22 Q01453 1/20 0.48
CAMK2A Q9UQM7 1/20 0.43
GABRR3 A8MPY1 1/20 0.42
GABRP O00591 1/20 0.42
GABRD O14764 1/20 0.42
HDAC3 O15379 1/20 0.42
GABBR2 O75899 1/20 0.42
CYP1A2 P05177 1/20 0.42
THRB P10828 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRB1 P18505 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRR1 P24046 1/20 0.42
GABRB3 P28472 1/20 0.42
GABRR2 P28476 1/20 0.42
SLC6A1 P30531 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL631910 0.89 TSHR (0.50) TSHRSLC22A6LMNACYP1A2KMT2A
Valeric Acid SCHEMBL12504185 0.86 AKR1B1 (0.56) TSHRSLC22A6LMNAHDAC3CYP1A2
Hexanoate SCHEMBL12504106 0.84 AKR1B1 (0.67) TSHRSLC22A6LMNACYP1A2BLM
SCHEMBL5161389 0.83
SCHEMBL8852178 0.83 TSHR (0.43) TSHRLMNANFKB1PMP22CYP1A2
SCHEMBL1289888 0.78 SLC22A6 (0.65) TSHRSLC22A6LMNANFKB1PMP22
SCHEMBL312723 0.78 SLC22A6 (0.65) TSHRSLC22A6LMNANFKB1PMP22
SCHEMBL19925 0.78 SLC22A6 (0.65) TSHRSLC22A6LMNANFKB1PMP22
SCHEMBL1479653 0.76 TSHR (0.44) TSHRLMNABLMEGLN1ALDH1A1
Glutarate SCHEMBL6701735 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8247341-B2 Procatalyst composition with silyl glutarate and method DOW GLOBAL TECHNOLOGIES LLC (US) 2012-08-21 US claimed
CN-102459358-A Procatalyst composition with silyl glutarate and method therefor DOW GLOBAL TECHNOLOGIES INC 2012-05-16 CN claimed
EP-2419458-A1 PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD Dow Global Technologies LLC (US) 2012-02-22 EP claimed
US-20100267911-A1 Procatalyst Composition with Silyl Glutarate and Method DOW GLOBAL TECHNOLOGIES INC. (US) 2010-10-21 US claimed
WO-2010120973-A1 PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD DOW GLOBAL TECHNOLOGIES INC. (US) 2010-10-21 WO claimed
EP-3592783-B1 ELECTRON DONORS FOR ZIEGLER-NATTA PRECATALYST PREPARATION AND CATALYST SYSTEM FOR OLEFIN POLYMERIZATION GRACE W R & CO (US) 2025-11-12 EP disclosed
US-8247341-B2 Procatalyst composition with silyl glutarate and method DOW GLOBAL TECHNOLOGIES LLC (US) 2012-08-21 US disclosed
US-8247341-B2 Procatalyst composition with silyl glutarate and method DOW GLOBAL TECHNOLOGIES LLC (US) 2012-08-21 US disclosed
US-8247341-B2 Procatalyst composition with silyl glutarate and method DOW GLOBAL TECHNOLOGIES LLC (US) 2012-08-21 US disclosed
CN-102459358-A Procatalyst composition with silyl glutarate and method therefor DOW GLOBAL TECHNOLOGIES INC 2012-05-16 CN disclosed
CN-102459358-A Procatalyst composition with silyl glutarate and method therefor DOW GLOBAL TECHNOLOGIES INC 2012-05-16 CN disclosed
CN-102459358-A Procatalyst composition with silyl glutarate and method therefor DOW GLOBAL TECHNOLOGIES INC 2012-05-16 CN disclosed
EP-2419458-A1 PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD Dow Global Technologies LLC (US) 2012-02-22 EP disclosed
EP-2419458-A1 PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD Dow Global Technologies LLC (US) 2012-02-22 EP disclosed
US-20100267911-A1 Procatalyst Composition with Silyl Glutarate and Method DOW GLOBAL TECHNOLOGIES INC. (US) 2010-10-21 US disclosed
US-20100267911-A1 Procatalyst Composition with Silyl Glutarate and Method DOW GLOBAL TECHNOLOGIES INC. (US) 2010-10-21 US disclosed
US-20100267911-A1 Procatalyst Composition with Silyl Glutarate and Method DOW GLOBAL TECHNOLOGIES INC. (US) 2010-10-21 US disclosed
WO-2010120973-A1 PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD DOW GLOBAL TECHNOLOGIES INC. (US) 2010-10-21 WO disclosed
WO-2010120973-A1 PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD DOW GLOBAL TECHNOLOGIES INC. (US) 2010-10-21 WO disclosed
WO-2010120973-A1 PROCATALYST COMPOSITION WITH SILYL GLUTARATE AND METHOD DOW GLOBAL TECHNOLOGIES INC. (US) 2010-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267911-A1 Procatalyst Composition with Silyl Glutarate and Method MPST, TST, TKT TSHR 3845/4885SLC22A6 793/4885LMNA 1306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.